Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Initial Lightbridge Fuel™ Material Samples Removed from Idaho National Laboratory’s Advanced Test Reactor
-
Uxin Highlights Operational Strength and Long-Term Growth Strategy at 2026 Investor Day
-
LEO Pharma to Showcase New Data Highlighting the Burden and Unmet Needs in Chronic Hand Eczema at ESCD 2026 in Copenhagen
-
e‑STORAGE to Deliver 426 MWh of Energy Storage in Florida
-
Simpson Spotlights a More Connected Approach to Memory Care for Alzheimer’s and Brain Awareness Month
-
NorthVault AI Unveils 43.75 MW AI Data Centre Campus in Ontario, With 4 MW Available Now
-
Keeper Security Brings Privileged Access Controls to Microsoft Teams With New Keeper Teams App
-
Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors
-
OXIO Launches Advanced Core Routing, Enabling AI, Real-Time Fraud Detection and Compliance in the Telecom Core
-
Mas Restaurant Group, Backed by Bessemer Investors, Sells Ohio Taco Bell Units to Southpaw
-
Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis
-
Dollar Tree Announces Secondary Block Trade by Selling Stockholders and Share Buyback
-
MRM Health Strengthens Board with Michel Detheux as Chairman and Hans-Jürgen Wörle as Independent Director as MH002 Advances Through Phase 2b
-
Constellation Announces Extension of Expiration for Exchange Offers
-
Yiren Digital Reports First Quarter 2026 Unaudited Financial Results
-
Agenus Announces Three-Year Survival Data from Phase 1b BOT+BAL Study in MSS Metastatic Colorectal Cancer to be Presented at ESMO GI 2026
-
FingerprintJS Surpasses 1 Million Weekly Downloads, Solidifying Position as the Leading Open-Source Browser Fingerprinting Library
-
Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial
-
ABBYY Strengthens Cloud Trust Compliance to Meet Growing Enterprise Demand for BSI C5 Assurance
-
FlightHub Becomes a One-Stop Shop for Travel Planning with Launch of Hotels and Summer Savings
-
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
-
Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial
-
GDS Concludes Successful 2026 Annual General Meeting with All Resolutions Passed, Including Election and Re-election of Directors
-
Calgon Carbon Wins AWWA Innovation Award for PFAS Destruction Breakthrough
-
Troilus Drills 157.5 Metres Grading 0.95 g/t AuEq While Targeting Inferred Material Within the Z87 Reserve Pit
-
Montauk Brewing Kicks Off Summer with 14th Anniversary Celebration, Limited Brew Barn Release and Beach Cleanup
-
Highlander Silver: Comprehensive Geophysical Program Maps Extensive System Concealed by Shallow Cover at Corani
-
Impact Analytics Research Identifies Holiday 2026's Defining Promotional Strategy: Broader Reach, Disciplined Depth
-
INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™
-
Winnebago Industries Reports Third Quarter Fiscal 2026 Results
-
Verano to Report Second Quarter 2026 Financial Results on August 5, 2026
-
Lithium Ionic Advances Construction Readiness at Bandeira; Secures Construction-Phase Water Access and Provides Engineering and Procurement Updates
-
Baker Hughes to Deliver Subsea Production Systems to Support Azule Energy’s Greater PAJ Development
-
Satellos to Present Clinical Program Updates at ICNMD 2026
-
Autolus Therapeutics to Participate in Upcoming Investor Conference
-
Manhattan Bridge Capital, Inc. Announces Payment of Quarterly Dividend
-
Irving Resources Discovers High-Grade Feeder at Omu Sinter
-
Herantis appoints experienced drug development expert Dr Juha Savola as Chief Medical Officer
-
AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet
-
Triple Flag Completes Acquisition of US$440 Million Gold Stream on the Ravenswood Gold Mine
-
Fixing of coupon rate effective from 1 July 2026
-
Treno Scope Launches “Data for All” Initiative, Empowering Developers in Vietnam and Thailand
-
High Templar Tech Announces Preliminary Results of Modified Dutch Auction Tender Offer
-
AMC Entertainment Holdings, Inc. Announces Closing of $200 Million Registered Direct Offering of Common Stock
-
Saudia Earns 2026 APEX Best Cabin Service in the Middle East Award
-
KKR Announces Intra-Quarter Update
-
Nexus IT Announces Independent Board of Directors Selection for Next Phase of Growth
-
Fixing of Coupon Interest Rate
-
TYLENOL® Introduces PainTalk to Break the Silence on Pain--So Relief Can Start Sooner
-
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), each with Trodelvy® (sacituzumab govitecan-hziy) as First-Line Treatment of PD-L1+ (CPS �
